Yesterday, the Tevogen Bio (Nasdaq: TVGN) continued to be in focus among investors and ended the day with gains of 26% as it gained more momentum. The rally came about after the company made an announcement about the products it was developing. Tevogen Bio Takes Lead in Developing Cell Therapies Designed to Eradicate Post-Procedure Human …
Continue reading “Tevogen Bio (Nasdaq: TVGN) Stock In Action On High Volume”